Mucopolysaccharidosis Newborn Screening Meeting
We are thrilled to extend this invitation to the 2025 MPS Newborn Screening Meeting, led by course directors Paul Orchard, MD, and Amy Gaviglio, MS, CGC. The event will be taking place on April 14–16, 2025, at the University of Minnesota’s McNamara Alumni Center. For your convenience, the meeting will also be accessible via live webinar.
Hosted by the University of Minnesota’s MPS Center, this event is a must-attend for professionals in genetics, pediatrics, and rare disease research. Dive into cutting-edge advancements in mucopolysaccharidosis (MPS) and newborn screening with industry leaders and top-notch experts.
For more information and to register, please visit the event webpage at z.umn.edu/MPSNewbornScreeningMeeting.
Additional Opportunities
If you are interested in submitting a poster for the event, please apply here.
To learn more about exhibiting opportunities, please complete this form.
We hope you’ll join us for this impactful gathering and look forward to seeing you there!
Date & Location
Monday, April 14, 2025, 4:30 PM - Wednesday, April 16, 2025, 5:00 PM, McNamara Alumni Center and as a Live Webinar, Minneapolis, MN
Target Audience
Professions - Laboratory Professional, Nurse, Other, Physician
Objectives
At the conclusion of this course, learners should be able to:
- Recognize the challenges in newborn screening for MPS disorders to ensure early and accurate diagnosis and establishment of phenotype and how this may influence interventions and improved patient outcomes.
- Identify the latest advancements in MPS treatments, including emerging therapies such as gene therapy, and how these may be employed in patient care strategies.
- Be aware of the importance of effective communication strategies and collaborative practices among multidisciplinary teams involved in the management of MPS to enhance care coordination.
- List key gaps in achieving optimal treatments for MPS disorders, including the role of genotype-phenotype and early detection and the risks/benefits of available treatment options.